2022
Exports
$11.6MWorld Rnk 71 / 208
Flag Rnk 61 / 790
2022
PRODUCT COMPLEXITY IN Vaccines, blood, antisera, toxins and cultures
1.38Rnk 75 / 1025
2022
Imports
$156MWorld Rnk 83 / 225
Flag Rnk 12 / 1129
2022
ECONOMIC COMPLEXITY of Paraguay
-0.34Rnk 81 / 133

About

Exports In 2022, Paraguay exported $11.6M in Vaccines, blood, antisera, toxins and cultures, making it the 71st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 61st most exported product in Paraguay. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Paraguay are: Uruguay ($4.84M), Brazil ($2.09M), France ($1.69M), Colombia ($1.42M), and Argentina ($435k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Paraguay between 2021 and 2022 were Uruguay ($3.01M), Brazil ($1.19M), and France ($376k).

Imports In 2022, Paraguay imported $156M in Vaccines, blood, antisera, toxins and cultures, becoming the 83rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 12th most imported product in Paraguay. Paraguay imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($33.6M), Germany ($20.6M), Belgium ($16.3M), Argentina ($12.6M), and Uruguay ($10.8M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Paraguay between 2021 and 2022 were Germany ($5.52M), Ireland ($2.38M), and Belgium ($2.31M).

Latest Trends

Jul 2024

Subnational Monthly Trade

View
Flow
Y-AXIS SCALE

For a full breakdown of trade patterns, visit the trend explorer or the product in country profile.

The following visualization shows the latest trends on Vaccines, blood, antisera, toxins and cultures. Countries are shown based on data availability.

* Using January 2020 exchange rates when trade data is reported in local currency.

Explore Latest Trends

Subscribe today to OEC pro and access the latest data

Sign Up

Historical Data

Trade Balance

Color
EXPORTS (2022)$11.6M
IMPORTS (2022)$156M
NET TRADE (2022)-$145M

In 2022, Paraguay exported $11.6M in Vaccines, blood, antisera, toxins and cultures. The main destinations of Paraguay exports on Vaccines, blood, antisera, toxins and cultures were Uruguay ($4.84M), Brazil ($2.09M), France ($1.69M), Colombia ($1.42M), and Argentina ($435k).

In 2022, Paraguay imported $156M in Vaccines, blood, antisera, toxins and cultures, mainly from United States ($33.6M), Germany ($20.6M), Belgium ($16.3M), Argentina ($12.6M), and Uruguay ($10.8M).

Explore Visualizations

Export Destinations (NaN)

Import Origins (NaN)

Market Growth

Flow
THE FASTEST GROWING Vaccines, blood, antisera, toxins and cultures EXPORT MARKETS FOR Paraguay WERE (2021 - 2022):
Uruguay$3.01M (165%)
Brazil$1.19M (134%)
France$376k (28.6%)
THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, blood, antisera, toxins and cultures BY Paraguay WERE (2021 - 2022):
Germany-$1.9M (-99.2%)
Bolivia-$163k (-87.6%)
Austria-$51k (-100%)

Change in Exports by Market (undefined - undefined)

Market Concentration

View
Flow
Type
In 2022, Paraguay's main exporting competitors in Vaccines, blood, antisera, toxins and cultures were:
In 2022, Paraguay's main importing competitors in Vaccines, blood, antisera, toxins and cultures were:

Explore Visualizations

Trade Value of Vaccines, blood, antisera, toxins and cultures by Exporters

Potential Exports

Potential Exports

Flow
View
TOP EXPORT POTENTIALBrazil+ $3.5M
N/AN/AN/A

Vaccines, blood, antisera, toxins and cultures’s highest export potential is Brazil. With an export gap of $3.5M.   Vaccines, blood, antisera, toxins and cultures’s highest import potential is N/A with an import gap of N/A.

See methodology.

Subscribe today to OEC pro and access the latest data

Sign Up

Have questions, comments, or concerns?
Send us an e-mail: support@oec.world
Follow @OECtoday on
Created, Designed, and Developed by:
In collaboration with